KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Inventory Average (2016 - 2025)

Historic Inventory Average for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $31.3 million.

  • Neogenomics' Inventory Average rose 3138.18% to $31.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year increase of 3138.18%. This contributed to the annual value of $25.5 million for FY2024, which is 510.19% up from last year.
  • Per Neogenomics' latest filing, its Inventory Average stood at $31.3 million for Q3 2025, which was up 3138.18% from $32.0 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Inventory Average registered a high of $32.0 million during Q2 2025, and its lowest value of $21.4 million during Q2 2021.
  • Over the past 5 years, Neogenomics' median Inventory Average value was $24.0 million (recorded in 2022), while the average stood at $24.6 million.
  • Per our database at Business Quant, Neogenomics' Inventory Average plummeted by 1183.34% in 2024 and then soared by 4688.06% in 2025.
  • Neogenomics' Inventory Average (Quarter) stood at $22.6 million in 2021, then increased by 6.29% to $24.0 million in 2022, then grew by 0.28% to $24.1 million in 2023, then rose by 6.21% to $25.6 million in 2024, then rose by 22.31% to $31.3 million in 2025.
  • Its Inventory Average stands at $31.3 million for Q3 2025, versus $32.0 million for Q2 2025 and $28.3 million for Q1 2025.